Beyond Mendel: incomplete dominance, codominance, multiple alleles, epistasis and polygenic traits
- Side by side
Most real traits do not split neatly 3 to 1. Blood groups, height and blood pressure follow rules that extend Mendel rather than break him.
What it is
Mendel's peas showed simple dominance, but alleles and genes can interact in other ways. In incomplete dominance the heterozygote is intermediate; in codominance both alleles show fully. Many genes have more than two alleles in the population. One gene can affect many traits (pleiotropy), and one gene can mask the effect of another (epistasis). Most common traits, such as height, blood pressure and skin colour, are polygenic: many genes with small effects, plus the environment. Segregation still holds in every case; only the link from genotype to phenotype is more complex.
What to know
- ABO: A and B are codominant with each other and both are dominant over O; people of group O have neither A nor B antigen.
- Penetrance is the share of people with a genotype who show the trait; expressivity is how strongly it shows.
- The environment changes the phenotype: the effects of phenylketonuria are prevented by a low-phenylalanine diet from birth.
- Polygenic traits form a bell-shaped distribution in the population.
Patterns that extend Mendel
| Pattern | What happens | Example |
|---|---|---|
| Complete dominance | The heterozygote looks like the dominant homozygote | Huntington disease (a dominant allele) |
| Incomplete dominance | The heterozygote is intermediate | Familial hypercholesterolaemia: high LDL in heterozygotes, far higher in homozygotes |
| Codominance | Both alleles are fully expressed | Blood group AB; both HbA and HbS are made in sickle cell trait |
| Multiple alleles | More than two alleles exist in the population | ABO blood groups: alleles A, B and O |
| Pleiotropy | One gene, many effects | Marfan syndrome (fibrillin-1): eye, heart and skeleton |
| Epistasis | One gene masks another | Bombay phenotype: no H antigen, so A and B antigens cannot be made |
| Polygenic and multifactorial | Many genes plus environment; continuous variation | Height, type 2 diabetes, high blood pressure |
Where this leads in medicine
- Blood transfusion and haemolytic disease of the newborn depend on ABO and Rh antigens.
- Two group A parents who are both AO can have a group O child, with a ¼ chance each time.
- Common diseases (diabetes, coronary disease, high blood pressure) are multifactorial: a family history raises the risk but does not follow 3 : 1 ratios.
Common traps
- Codominance and incomplete dominance are the same: in codominance both show side by side; in incomplete dominance they blend.
- A trait is simply dominant or recessive: it depends on what you measure; sickle cell trait looks recessive for anaemia but codominant at the protein level.
- A dominant condition never skips a generation: reduced penetrance can make it seem to.
- Multifactorial means not genetic: genes matter, but no single gene decides.
Test yourself
Think of the answer, then tap the question to see it.
Two parents with blood group A have a child with group O. How is that possible?
Both parents are AO; each passes O with a ½ chance, so the child is OO with a ¼ chance.
Why is blood group AB an example of codominance rather than incomplete dominance?
Both A and B antigens are fully present on the red cells; nothing is blended or intermediate.
Why can a dominant condition appear to skip a generation?
Reduced penetrance: a person can carry the allele without showing the trait, and still pass it on.
Elsewhere in DurgiPedia
- Inheritance concepts, genotype–phenotype and the pedigree
- Complex traits: familial risk, twins, heritability and polygenic scores
Connections
Educational content for students. The numbers on the calculation pages are chemistry exercises, not doses or treatment instructions.
Sources: Codominance (National Human Genome Research Institute (NHGRI), 2026); Epistasis (National Human Genome Research Institute (NHGRI), 2026); Polygenic Trait (National Human Genome Research Institute (NHGRI), 2026); What are reduced penetrance and variable expressivity?: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
